Latest Financials News

Eden Innovations has appointed Dr Allan Godsk Larsen as Managing Director to spearhead its global growth, leveraging his deep expertise in carbon nanotube technology amid strong commercial momentum and significant debt reduction.

Flynn Gold has reported exceptional tungsten assays up to 14.75% WO3 at its Gorge Creek Prospect in northeast Tasmania, alongside elevated precious metals. The discovery opens a new chapter in the company’s critical minerals exploration, with drilling planned at multiple projects.

Celsius Resources Limited has had its trading suspension lifted following an announcement about its Supreme Court application challenging the validity of its prior auditor's 2011 resignation.

Celsius Resources has secured a Supreme Court order validating its auditor appointment and prior share issues, paving the way for its shares to be reinstated on the ASX.

US Masters Residential Property Group aims to divest its entire portfolio by the end of 2026, signalling an end to its operations. The group will prepare 2025 financials on a non-going concern basis, reflecting this strategic wind-down.

Australian Foundation Investment Company Limited has updated its interim and special dividend details, including foreign currency exchange rates and pricing for its Dividend Reinvestment and Substitution Share Plans.

Bhagwan Marine Ltd has announced a transformative $120 million acquisition of Riverside Marine Holdings, significantly enhancing its scale, profitability, and market reach. The deal is expected to lift FY26 revenue to $346 million and deliver a 14% EPS accretion.

Bhagwan Marine Limited has announced a transformative acquisition of Riverside Marine Holdings for up to $130 million, significantly boosting its scale, service diversity, and earnings potential.

Cannindah Resources has successfully raised over $11 million through the first tranche of its share placement, with the second tranche awaiting shareholder approval in March 2026.

Dexus Convenience Retail REIT has reported solid half-year results for 2026, underpinned by resilient income growth and a $19.8 million uplift in portfolio valuation. The fund maintains a conservative capital structure while advancing key development projects.

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.

Dexus Convenience Retail REIT (DXC) reports solid HY26 results with strong income growth and high occupancy, while advancing strategic development projects to enhance its metro and highway retail footprint.